Global Gaucher Disease Market Status and Outlook 2018-2025

July 2018 | 148 pages | ID: G966234A059EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Sanofi
• Shire
• Actelion Pharma
• Pfizer

Market by Type

• Enzyme replacement therapy
• Substrate reduction therapy

Market by Application

• Non-neuronopathic Gaucher disease
• Neuronopathic Gaucher disease

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Gaucher Disease Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Enzyme replacement therapy
  3.1.2 Substrate reduction therapy
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Non-neuronopathic Gaucher disease
  4.1.2 Neuronopathic Gaucher disease
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Enzyme replacement therapy Production by Region
    6.1.1.2 Substrate reduction therapy Production by Region
  6.1.2 Production by Application
    6.1.2.1 Non-neuronopathic Gaucher disease Production by Region
    6.1.2.2 Neuronopathic Gaucher disease Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Enzyme replacement therapy Demand by Region
    6.2.1.2 Substrate reduction therapy Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Non-neuronopathic Gaucher disease Demand by Region
    6.2.2.2 Neuronopathic Gaucher disease Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Sanofi
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Shire
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Actelion Pharma
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Gaucher Disease Industry Dynamics & Regulations List
Table Global Gaucher Disease Sales Revenue, Cost and Margin, 2015-2018E
Table Global Gaucher Disease Market Status by Type 2015-2018E, in USD Million
Table Global Gaucher Disease Market Status by Application 2015-2018E, in USD Million
Table Global Gaucher Disease Market Status by Application 2015-2018E, in Volume
Table Global Gaucher Disease Market by Region 2015-2018E, in USD Million
Table Global Gaucher Disease Market Share by Region in 2018, in USD Million
Table Global Gaucher Disease Market by Region 2015-2018E, in Volume
Table Global Gaucher Disease Market Share by Region in 2018, in Volume
Table Enzyme replacement therapy Production Value by Region 2015-2018E, in USD Million
Table Enzyme replacement therapy Production Volume by Region 2015-2018E, in Volume
Table Substrate reduction therapy Production Value by Region 2015-2018E, in USD Million
Table Substrate reduction therapy Production Volume by Region 2015-2018E, in Volume
Table Non-neuronopathic Gaucher disease Production Value by Region 2015-2018E, in USD Million
Table Non-neuronopathic Gaucher disease Production Volume by Region 2015-2018E, in Volume
Table Neuronopathic Gaucher disease Production Value by Region 2015-2018E, in USD Million
Table Neuronopathic Gaucher disease Production Volume by Region 2015-2018E, in Volume
Table Enzyme replacement therapy Market Size by Region 2015-2018E, in USD Million
Table Enzyme replacement therapy Market Size by Region 2015-2018E, in Volume
Table Substrate reduction therapy Market Size by Region 2015-2018E, in USD Million
Table Substrate reduction therapy Market Size by Region 2015-2018E, in Volume
Table Non-neuronopathic Gaucher disease Market Size by Region 2015-2018E, in USD Million
Table Non-neuronopathic Gaucher disease Market Size by Region 2015-2018E, in Volume
Table Neuronopathic Gaucher disease Market Size by Region 2015-2018E, in USD Million
Table Neuronopathic Gaucher disease Market Size by Region 2015-2018E, in Volume
Table GlobalGaucher Disease Forecast by Type 2019F-2025F, in USD Million
Table Gaucher Disease Forecast by Type 2019F-2025F, in Volume
Table Gaucher Disease Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Gaucher Disease Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Gaucher Disease Market Forecast by Region 2019F-2025F, in USD Million
Table Gaucher Disease Market Forecast by Region 2019F-2025F, in Volume
Table Sanofi Information
Table Gaucher Disease Sales, Cost, Margin of Sanofi
Table Shire Information
Table Gaucher Disease Sales, Cost, Margin of Shire
Table Actelion Pharma Information
Table Gaucher Disease Sales, Cost, Margin of Actelion Pharma
Table Pfizer Information
Table Gaucher Disease Sales, Cost, Margin of Pfizer
Table Global Gaucher Disease Sales Revenue by Company 2015-2017, in USD Million
Table Global Gaucher Disease Sales Volume by Company 2015-2017, in Volume
Table Global Gaucher Disease Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Gaucher Disease Picture
Figure Gaucher Disease Industry Chain Diagram
Figure Global Gaucher Disease Sales Revenue 2015-2018E, in USD Million
Figure Global Gaucher Disease Sales Volume 2015-2018E, in Volume
Figure Global Gaucher Disease Market Status by Type 2015-2018E, in Volume
Figure North America Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure North America Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure Europe Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure Europe Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure South America Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure South America Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure Middle East Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure Africa Gaucher Disease Market Size and Growth 2015-2018E, in USD Million
Figure Africa Gaucher Disease Market Size and Growth 2015-2018E, in Volume
Figure Global Gaucher Disease Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Gaucher Disease Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Gaucher Disease Sales Price Forecast 2019F-2025F
Figure Global Gaucher Disease Gross Margin Forecast 2019F-2025F
Figure Global Gaucher Disease Sales Revenue by Company in 2018, in USD Million
Figure Global Gaucher Disease Price by Company in 2018
Figure Global Gaucher Disease Gross Margin by Company in 2018